Amandeep Thakur
250 Wuxing Street
Taipei, TNQ 11031, Taiwan
Taipei, TNQ 11031, Taiwan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications
Dual SYK-HDAC Inhibitor Elicits Striking Efficacy against Acute Myeloid Leukemia: Rational Design, Synthesis, and Biological Evaluation.
Journal: Journal of medicinal chemistry
Published: June 09, 2026
KDM1A/HDAC2-driven epigenetic dysregulation maintains a drug-resistant, relapse-initiating glioblastoma cell niche at the peri-tumoral margin.
Journal: Biochemical pharmacology
Published: February 23, 2026
Palladium-catalysed synthesis of small-molecule epigenetic inhibitors as anticancer therapeutics.
Journal: Journal of enzyme inhibition and medicinal chemistry
Published: February 16, 2026
Multi-Targeting Ligands as Prospective Therapeutics for Alzheimer's Disease, a Prevalent Neurodegenerative Disorder: Mechanistic Insights, Emerging Targets and Drug Discovery Campaigns.
Journal: Medicinal research reviews
Published: September 06, 2025
Contribution of Prostaglandin E2-Induced Neuronal Excitation to Drug Resistance in Glioblastoma Countered by a Novel Blood-Brain Barrier Crossing Celecoxib Derivative.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: April 08, 2025
Advancing glioblastoma therapy: Learning from the past and innovations for the future.
Journal: Cancer letters
Published: November 14, 2024
Scaffold hopping approaches for dual-target antitumor drug discovery: opportunities and challenges.
Journal: Expert opinion on drug discovery
Published: October 18, 2024
Spleen tyrosine kinase (SYK): an emerging target for the assemblage of small molecule antitumor agents.
Journal: Expert opinion on investigational drugs
Published: August 03, 2024
Leveraging a rationally designed veliparib-based anilide eliciting anti-leukemic effects for the design of pH-responsive polymer nanoformulation.
Journal: European journal of medicinal chemistry
Published: March 26, 2024
Recent advances and future directions on small molecule VEGFR inhibitors in oncological conditions.
Journal: European journal of medicinal chemistry
Published: March 07, 2024
Flavone-based dual PARP-Tubulin inhibitor manifesting efficacy against endometrial cancer.
Journal: Journal of enzyme inhibition and medicinal chemistry
Published: November 03, 2023
Small molecule tractable PARP inhibitors: Scaffold construction approaches, mechanistic insights and structure activity relationship.
Journal: Bioorganic chemistry
Published: August 09, 2023
Last Updated: 09/26/2026